ARTICLE | Company News
Sangamo, Onyx in cancer deal
April 5, 2001 7:00 AM UTC
The companies will develop cancer therapeutics using SGMO's zinc finger DNA-binding protein transcription factor (ZFP TF) technology and ONXX's Therapeutic Viruses selectively replicating adenovirus p...